HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leonardo Sorci Selected Research

nicotinic acid mononucleotide adenylyltransferase (nicotinate nucleotide adenylyltransferase)

1/2019Novel Antimycobacterial Compounds Suppress NAD Biogenesis by Targeting a Unique Pocket of NaMN Adenylyltransferase.
8/2016Biological Activities of the Essential Oil from Erigeron floribundus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Leonardo Sorci Research Topics

Disease

2Tuberculosis (Tuberculoses)
01/2019 - 02/2014
1Carcinogenesis
04/2021
1Infections
01/2020
1Granuloma
01/2020
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2020
1Latent Tuberculosis
01/2020
1Inflammation (Inflammations)
11/2019
1Neoplasms (Cancer)
01/2019
1African Trypanosomiasis (Nagana)
08/2016
1Carcinoma (Carcinomatosis)
08/2016
1Genomic Instability
11/2014
1Starvation
02/2014

Drug/Important Bio-Agent (IBA)

7NAD (NADH)IBA
04/2021 - 02/2014
3Pharmaceutical PreparationsIBA
01/2020 - 02/2014
2EnzymesIBA
01/2019 - 01/2019
2nicotinic acid mononucleotide adenylyltransferase (nicotinate nucleotide adenylyltransferase)IBA
01/2019 - 08/2016
1Immunologic Factors (Immunomodulators)IBA
04/2021
1Adenosine (Adenocard)FDA LinkGeneric
04/2021
1Adenosine Diphosphate (ADP)IBA
04/2021
1Proteins (Proteins, Gene)FDA Link
04/2021
1Drug CombinationsIBA
01/2020
1LigandsIBA
11/2019
1Toll-Like Receptor 4IBA
11/2019
1nicotinate phosphoribosyltransferaseIBA
11/2019
1Antitubercular AgentsIBA
01/2019
1AntioxidantsIBA
08/2016
1Volatile Oils (Essential Oils)IBA
08/2016
1Tocopherols (Tocopherol)IBA
08/2016
1Anti-Bacterial Agents (Antibiotics)IBA
08/2016
1CarbonIBA
02/2014

Therapy/Procedure

1Duration of Therapy
01/2020